Please assess the completion status of the following clinical trial:

Trial Title: Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. established influenza A or B infection by virologic tests~2. age \>/=18 years~3. present within 4 days from illness onset~4. clinical evidence of LRTI and require hospital care~5. require antiviral (oseltamivir) treatment~6. able to provide written, informed consent.~Exclusion Criteria:~1. patients on immunosuppressants~2. pregnant or lactating woman~3. known hepatic failure, end-stage renal failure, cardiac arrhythmia (e.g. prolonged corrected QT interval \>450 msec)~4. known contraindications to azithromycin (e.g. allergic reaction)~5. lack of consent for study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Macrolide treatment (Type: EXPERIMENTAL): Azithromycin 500 mg daily for 5 days
- No macrolide treatment (Type: NO_INTERVENTION): No azithromycin

Based on this trial design, predict the completion outcome and termination type (if applicable).